Other Conditions
46,094 recruiting
Trials for conditions not in our main categories
Showing 1–20 of 46,094 trials
Recruiting
Phase 1
A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3
Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
Boehringer Ingelheim300 enrolled12 locationsNCT04429087
Recruiting
Development of a Patient-Centered Assessment Tool for Pain During Cesarean Delivery
Elective Cesarean Delivery
University Hospital, Basel, Switzerland12 enrolled1 locationNCT07409012
Recruiting
International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform
Severe Native Aortic Stenosis
IRCCS Policlinico S. Donato1,000 enrolled1 locationNCT07359898
Recruiting
Phase 1
Mifepristone vs Misoprostol
Cervical Preparation
Montefiore Medical Center94 enrolled1 locationNCT06502158
Recruiting
Phase 2Phase 3
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI)138 enrolled416 locationsNCT04402788
Recruiting
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Trisomy 8 MosaicismTrisomy 8 Associated Autoinflammatory DiseaseMucosal Ulcerations
National Institute of Allergy and Infectious Diseases (NIAID)750 enrolled1 locationNCT07683104
Recruiting
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
AlcoholismSubstance-Related Disorders
National Institute on Drug Abuse (NIDA)10,000 enrolled1 locationNCT06676059
Recruiting
SLC6A1-NDD Prospective Longitudinal Natural History Study
SLC6A1 Neurodevelopmental Disorder (NDD)Developmental and Epileptic Encephalopathies (DEE)
UCB Biopharma SRL60 enrolled3 locationsNCT07531511
Recruiting
Phase 2Phase 3
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.153 enrolled43 locationsNCT07159841
Recruiting
Deciphering the Genetic Architecture of Autoimmune Diseases
Autoimmune Diseases
National Human Genome Research Institute (NHGRI)300 enrolled2 locationsNCT06948110
Recruiting
Phase 3
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
National Cancer Institute (NCI)336 enrolled18 locationsNCT07388524
Recruiting
Phase 2
Venous Ethanol for Ventricular Tachycardia
Ventricular TachycardiaIschemic Cardiomyopathy
The Methodist Hospital Research Institute156 enrolled1 locationNCT05511246
Recruiting
Phase 3
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
Degenerative Disc Disease
DiscGenics, Inc.162 enrolled19 locationsNCT07254806
Recruiting
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy
National Institute of Neurological Disorders and Stroke (NINDS)700 enrolled1 locationNCT01730131
Recruiting
Not Applicable
VNS Algorithm for Advanced Dosing
Epilepsies
Fernando Vale80 enrolled1 locationNCT07725601
Recruiting
Phase 3
A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Thrombocytopenia, Neonatal Alloimmune
Janssen Research & Development, LLC39 enrolled21 locationsNCT06449651
Recruiting
Chronic Subdural Hematoma Embolization With Detachable Coils
Chronic Subdural Hemorrhage (cSDH)
Icahn School of Medicine at Mount Sinai150 enrolled1 locationNCT07291427
Recruiting
Not Applicable
Onyx™ Liquid Embolic IDE Clinical Study
TraumaUlcerGI Bleed+2 more
Medtronic Endovascular119 enrolled18 locationsNCT06742801
Recruiting
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Aging
National Institute on Aging (NIA)400 enrolled1 locationNCT07099053
Recruiting
Phase 2
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
Neuroendocrine CarcinomaCarcinoma, NeuroendocrineTumor, Neuroendocrine+2 more
National Cancer Institute (NCI)60 enrolled1 locationNCT06406465